Abstract
Background: Increasing interest arises in the association between short–term meteorological exposure and scarlet fever risk, but the association with individual level infection risk remains poorly understood. Methods: We collected weather data from ERA5 Land (hourly, 9 km * 9 km) and aggregated into daily exposures to match all scarlet fever cases data in Jiangsu, reported the Nationwide Notifiable Infectious Diseases Reporting Information System from 2005 to 2023. We conducted a time–stratified case–crossover study with associations quantified by odds ratio (ORs) with confidence interval (CI) from conditional logistic regressions with distributed lag non-linear models. Results: The odds ratios are generally significant with a 2–5 days lag, peaking at 3 days: 0.991 (95% CI: 0.986, 0.995) for temperature, 0.995 (95% CI: 0.994, 0.996) for relative humidity, 0.994 (95% CI: 0.990, 0.997) for total precipitation, 1.009 (95% CI: 1.005, 1.012) for solar radiation, and 1.088 (95% CI: 1.057, 1.120) for surface pressure. For non-linear effects, temperature showed a reversed U–shaped curve with peak risk between 15.17°C and 19°C and fluctuated risk at extremely low temperatures (below −5°C). Relative humidity posed a higher risk between 56% and 80%. Children aged over 6 exhibit greater susceptibility with stronger associations in temperature and surface pressure. Stronger associations were found in the post–COVID–19 era (2020—2023), particularly for temperature, solar radiation, and surface pressure. Conclusions: Our study suggested significant non-linear associations between meteorological factors and scarlet fever risk, and provided some insights into the vulnerable children and the immune debt after COVID–19.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This research was supported by the Jiangsu Province 333 project, National Key R&D Program of China (2024YFC2310403). This research was partially supported by the Top Talent Awards Project Fund (RDF TP 0023, RDF TP 0030) and the Postgraduate Research Fund (PGRS2112022) at Xian Jiaotong-Liverpool University.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics committee of Xi'an Jiaotong-Liverpool University Research Ethics Committee gave ethical approval for this work (0010000089620241213145342).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.